Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Partially-Blinded, Active Comparator-Controlled, Dose-Ranging, Safety, Tolerability, and Immunogenicity Phase 1/2 Study of an Adjuvanted Seasonal Recombinant Quadrivalent VLP Influenza Vaccine in Adults 65 Years of Age and Older

NCT04622592 is registered in ClinicalTrials.gov with Medicago as lead sponsor.

NCT NCT04622592
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04622592 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Partially-Blinded, Active Comparator-Controlled, Dose-Ranging, Safety, Tolerability, and Immunogenicity Phase 1/2 Study of an Adjuvanted Seasonal Recombinant Quadrivalent VLP Influenza Vaccine in Adults 65 Years of Age and Older
Lead sponsor
Medicago
Phase
Phase 1/2
Overall status
Completed
Start date
November 2, 2020
Completion date
April 26, 2022
Enrollment
209 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

influenza